Home LiteratureArticle Details
PMID: 12969267 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.

Journal of neurochemistry ·Vol. 87 ·No. 1 ·2003-10-00 ·Pages 205-19

Fasulo WH, Hemby SE

Abstract

Antipsychotic drugs require a treatment regimen of several weeks before clinical efficacy is achieved in patient populations. While the biochemical mechanisms underlying the delayed temporal profile remain unclear, molecular adaptations in specific neuroanatomical loci are likely involved. Haloperidol-induced changes in gene expression in various brain regions have been observed; however, alterations in distinct neuronal populations have remained elusive. The present study examined changes in gene expression profiles of ventral tegmental area (VTA) and substantia nigra (SN) tyrosine hydroxylase immunopositive neurons following 1, 10 or 21 days of haloperidol administration (0.5 mg/kg/day). Macroarrays were used to study the expression of receptors, signaling proteins, transcription factors and pre- and post-synaptic proteins. Data were analyzed using conventional statistical procedures as well as self-organizing maps (SOM) to elucidate conserved patterns of expression changes. Results show statistically significant haloperidol-induced and time-dependent alterations in 17 genes in the VTA and 25 genes in the SN, including glutamate and GABA receptor subunits, signaling proteins and transcription factors. SOMs revealed distinct patterns of gene expression changes in response to haloperidol. Understanding how gene expression is altered over a clinically relevant time course of haloperidol administration may provide insight into the development of antipsychotic efficacy as well as the underlying pathology of schizophrenia.

MeSH Terms
Analysis of Variance Animals Antipsychotic Agents/pharmacology Cluster Analysis Dopamine/metabolism Dopamine Antagonists/pharmacology Gene Expression/drug effects Gene Expression Profiling Haloperidol/pharmacology Lasers Male Mesencephalon/cytology,drug effects,metabolism Neurons/cytology,drug effects,metabolism Oligonucleotide Array Sequence Analysis Rats Rats, Sprague-Dawley Substantia Nigra/cytology,drug effects,metabolism Time Factors Tyrosine 3-Monooxygenase/biosynthesis Ventral Tegmental Area/cytology,drug effects,metabolism
Chemicals
Antipsychotic Agents Dopamine Antagonists Tyrosine 3-Monooxygenase Haloperidol Dopamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fasulo Wendy H
Department of Pharmacology, Yerkes National Primate Research Center, Neuroscience Division, Emory University School of Medicine, Atlanta, GA, USA.
Hemby Scott E
References (76)
76 references, click to expand
  1. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques.
    Ann Neurol. 1999 Feb;45(2):174-81 PMID: 9989619
  2. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2907-12 PMID: 10077610
  3. A glutamatergic deficiency model of schizophrenia.
    Br J Psychiatry Suppl. 1999;(37):2-6 PMID: 10211132
  4. NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum.
    Synapse. 1999 Jun 15;32(4):243-53 PMID: 10332800
  5. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.
    Am J Pathol. 1999 Jun;154(6):1857-66 PMID: 10362812
  6. Analysis of gene expression data using self-organizing maps.
    FEBS Lett. 1999 May 21;451(2):142-6 PMID: 10371154
  7. Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate).
    Neuropsychopharmacology. 1999 Aug;21(2):211-7 PMID: 10432469
  8. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins.
    Neurosci Lett. 1999 Oct 8;273(3):147-50 PMID: 10515180
  9. Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.
    J Neurosci. 2000 Feb 1;20(3):1229-39 PMID: 10648727
  10. No changes in dopamine D(1) receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements induced by long-term haloperidol administration.
    Brain Res. 2000 Mar 24;859(2):394-7 PMID: 10719094
  11. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol.
    J Neurosci. 2002 Feb 15;22(4):1407-13 PMID: 11850467
  12. Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain.
    J Pharmacol Exp Ther. 2002 Apr;301(1):197-209 PMID: 11907174
  13. Glutamate receptor expression in schizophrenic brain.
    Brain Res Brain Res Rev. 2000 Mar;31(2-3):288-94 PMID: 10719155
  14. Intracellular modulation of NMDA receptor function by antipsychotic drugs.
    J Neurosci. 2000 Jun 1;20(11):4011-20 PMID: 10818136
  15. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons.
    Ann Neurol. 2000 Jul;48(1):77-87 PMID: 10894219
  16. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
    Neuron. 2000 Oct;28(1):53-67 PMID: 11086983
  17. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
    Neuroscience. 2000;101(4):815-50 PMID: 11113332
  18. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons.
    Eur J Neurosci. 2001 Jan;13(1):57-67 PMID: 11135004
  19. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
    Neuropsychopharmacology. 2001 May;24(5):545-52 PMID: 11282254
  20. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
    Am J Psychiatry. 2001 Sep;158(9):1367-77 PMID: 11532718
  21. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.
    Biol Psychiatry. 2001 Nov 15;50(10):729-42 PMID: 11720691
  22. Transcriptional profiling reveals strict boundaries between hippocampal subregions.
    J Comp Neurol. 2001 Dec 17;441(3):187-96 PMID: 11745644
  23. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.
    J Neurosci. 2002 Apr 1;22(7):2718-29 PMID: 11923437
  24. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.
    Arch Gen Psychiatry. 2002 Jul;59(7):631-40 PMID: 12090816
  25. cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.
    J Neurochem. 2002 Sep;82(6):1533-9 PMID: 12354301
  26. Functional genomics and psychiatric illness.
    Prog Brain Res. 2002;138:375-93 PMID: 12432779
  27. Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain.
    Mol Pharmacol. 2002 Dec;62(6):1314-20 PMID: 12435798
  28. Antipsychotic drug treatment induces differential gene expression in the rat cortex.
    J Neurochem. 2002 Dec;83(5):1043-53 PMID: 12437575
  29. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.
    J Comp Neurol. 2003 Feb 3;456(2):176-83 PMID: 12509874
  30. Molecular and functional profiling of memory CD8 T cell differentiation.
    Cell. 2002 Dec 13;111(6):837-51 PMID: 12526810
  31. Global gene expression analysis of single cells.
    Curr Opin Drug Discov Devel. 2003 Mar;6(2):231-6 PMID: 12669459
  32. Molecular profiling of midbrain dopamine regions in cocaine overdose victims.
    J Neurochem. 2003 May;85(4):911-24 PMID: 12716423
  33. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity.
    J Neurosci. 2003 May 1;23(9):3607-15 PMID: 12736331
  34. Rapid reversal of tardive dyskinesia.
    Am J Psychiatry. 1973 Oct;130(10):1159 PMID: 4728916
  35. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
    Science. 1976 Apr 30;192(4238):481-3 PMID: 3854
  36. Antipsychotic drug doses and neuroleptic/dopamine receptors.
    Nature. 1976 Jun 24;261(5562):717-9 PMID: 945467
  37. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Psychol Med. 1978 Nov;8(4):657-65 PMID: 364517
  38. The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action.
    Postgrad Med. 1979 Apr;65(4):108-11, 114-9 PMID: 34141
  39. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects.
    Postgrad Med. 1979 Apr;65(4):123-8 PMID: 34142
  40. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Annu Rev Neurosci. 1980;3:23-41 PMID: 6106450
  41. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    J Neurosci. 1983 Aug;3(8):1607-19 PMID: 6135762
  42. Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences.
    J Neurosci. 1987 Mar;7(3):629-33 PMID: 2881987
  43. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    J Neurochem. 1990 May;54(5):1755-60 PMID: 1969939
  44. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
    J Mol Neurosci. 1990;2(3):155-61 PMID: 1703431
  45. Recent advances in the phencyclidine model of schizophrenia.
    Am J Psychiatry. 1991 Oct;148(10):1301-8 PMID: 1654746
  46. Co-localization of tyrosine hydroxylase and glutamate decarboxylase in a subpopulation of single nigrotectal projection neurons.
    Brain Res. 1991 Sep 6;558(2):239-44 PMID: 1685932
  47. Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment.
    Neurosci Res. 1991 Nov;12(3):440-5 PMID: 1664925
  48. Analysis of gene expression in single live neurons.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3010-4 PMID: 1557406
  49. D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment.
    Brain Res. 1992 Mar 13;575(1):47-56 PMID: 1387032
  50. The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia.
    J Neural Transm Suppl. 1992;36:91-131 PMID: 1356143
  51. Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum.
    J Mol Neurosci. 1992;3(4):197-201 PMID: 1390000
  52. Two types of neurone in the rat ventral tegmental area and their synaptic inputs.
    J Physiol. 1992 May;450:455-68 PMID: 1331427
  53. In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.
    Naunyn Schmiedebergs Arch Pharmacol. 1992 Dec;346(6):637-43 PMID: 1362452
  54. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields.
    Synapse. 1993 Mar;13(3):251-63 PMID: 8497810
  55. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
    Brain Res Mol Brain Res. 1994 Apr;23(1-2):14-20 PMID: 7518029
  56. Clozapine produces potent antidopaminergic effects anatomically specific to the mesolimbic system.
    J Clin Psychiatry. 1994 Sep;55 Suppl B:15-22 PMID: 7961561
  57. Brain region effects of clozapine on amino acid and monoamine transmission.
    J Clin Psychiatry. 1994 Sep;55 Suppl B:8-14 PMID: 7961581
  58. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
    J Pharmacol Exp Ther. 1994 Dec;271(3):1181-92 PMID: 7996424
  59. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
    Synapse. 1994 Nov;18(3):178-89 PMID: 7531873
  60. The effects of haloperidol on dopamine receptor gene expression.
    Exp Neurol. 1994 Dec;130(2):288-303 PMID: 7867758
  61. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs.
    J Neurosci. 1995 Mar;15(3 Pt 2):2453-61 PMID: 7891180
  62. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.
    Brain Res Mol Brain Res. 1995 Apr;29(2):211-23 PMID: 7609609
  63. Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein.
    Neuroscience. 1995 Apr;65(4):1051-61 PMID: 7617161
  64. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
    Am J Psychiatry. 1996 Feb;153(2):151-62 PMID: 8561194
  65. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Neuropsychopharmacology. 1996 May;14(5):301-7 PMID: 8703299
  66. Effects of haloperidol on the activity and membrane physiology of substantia nigra dopamine neurons recorded in vitro.
    Brain Res. 1996 Mar 25;713(1-2):44-52 PMID: 8724974
  67. Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain.
    Psychopharmacology (Berl). 1996 Dec;128(4):362-70 PMID: 8986007
  68. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs.
    Trends Neurosci. 1997 Jan;20(1):31-7 PMID: 9004417
  69. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study.
    Brain Res Mol Brain Res. 1997 Feb;44(1):92-8 PMID: 9030702
  70. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.
    Biol Psychiatry. 1997 Mar 15;41(6):636-43 PMID: 9066986
  71. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum.
    Brain Res Mol Brain Res. 1997 Jul;47(1-2):331-8 PMID: 9221932
  72. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice.
    Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12157-61 PMID: 9342379
  73. The glutamatergic dysfunction hypothesis for schizophrenia.
    Harv Rev Psychiatry. 1996 Jan-Feb;3(5):241-53 PMID: 9384954
  74. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs.
    Brain Res Mol Brain Res. 1997 Oct 15;50(1-2):136-42 PMID: 9406928
  75. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.
    J Neurochem. 1998 Dec;71(6):2454-64 PMID: 9832144
  76. Gene expression profiles of laser-captured adjacent neuronal subtypes.
    Nat Med. 1999 Jan;5(1):117-22 PMID: 9883850
Article Info
Journal
Journal of neurochemistry
Abbr.
J Neurochem
ISSN
0022-3042
Published
2003-10-00
Pages
205-19
Language
English
Region
England
NLM ID
2985190R
PMCID
PMC3843351
Subset
IM
Grants
NIDA NIH HHS · F31 DA015941 · United States
NIDA NIH HHS · R01 DA013772-03 · United States
NIDA NIH HHS · DA15941 · United States
NIDA NIH HHS · DA13772 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com